The modernization of clinical trials and the role of decentralized clinical trials are becoming an important focus in the industry. Life sciences organizations are facing a changing ecosystem. Patient access-diversity is driving the need for different types of interactions with the various stakeholders, as well as with the sponsors. It is also impacting how process, technology, interoperability, and digital maturity, are playing a role in providing patient-centric and patient-site enabled services.